References
C. Odiatis, I. Savva, M. Pieri, P. Ioannou, P. Petrou, G. Papagregoriou, K. Antoniadou, N. Makrides, C. Stefanou, D. G. Ljubanović, G. Nikolaou, D.-B. Borza, K. Stylianou, O. Gross, C. Deltas, A glycine substitution in the collagenous domain of Col4a3 in mice recapitulates late onset Alport syndrome. Matrix Biol Plus. 9, 100053 (2021).
R. A. P. M. Perera, R. Ko, O. T. Y. Tsang, D. S. C. Hui, M. Y. M. Kwan, C. J. Brackman, E. M. W. To, H.-L. Yen, K. Leung, S. M. S. Cheng, K. H. Chan, K. C. K. Chan, K.-C. Li, L. Saif, V. R. Barrs, J. T. Wu, T. H. C. Sit, L. L. M. Poon, M. Peiris, Evaluation of a SARS-CoV-2 Surrogate Virus Neutralization Test for Detection of Antibody in Human, Canine, Cat, and Hamster Sera. J. Clin. Microbiol. 59 (2021).
E. H. Y. Lau, O. T. Y. Tsang, D. S. C. Hui, M. Y. W. Kwan, W.-H. Chan, S. S. Chiu, R. L. W. Ko, K. H. Chan, S. M. S. Cheng, R. A. P. M. Perera, B. J. Cowling, L. L. M. Poon, M. Peiris, Neutralizing antibody titres in SARS-CoV-2 infections. Nat. Commun. 12, 63 (2021).
A. E. Powell, K. Zhang, M. Sanyal, S. Tang, P. A. Weidenbacher, S. Li, T. D. Pham, J. E. Pak, W. Chiu, P. S. Kim, A Single Immunization with Spike-Functionalized Ferritin Vaccines Elicits Neutralizing Antibody Responses against SARS-CoV-2 in Mice. ACS Cent Sci. 7, 183–199 (2021).
T. Kaneko, S. Esmail, C. Voss, C. Martin, M. Slessarev, O. Hovey, X. Liu, M. Ye, S. Kim, D. Fraser, S. Li, System-wide hematopoietic and immune signaling aberrations in COVID-19 revealed by deep proteome and phosphoproteome analysis. Research Square (2021).
H. Lv, O. T.-Y. Tsang, R. T. Y. So, Y. Wang, M. Yuan, H. Liu, G. K. Yip, Q. W. Teo, Y. Lin, W. Liang, J. Wang, W. W. Ng, I. A. Wilson, J. S. Malik Peiris, N. C. Wu, C. K. P. Mok, Homologous and heterologous serological response to the N-terminal domain of SARS-CoV-2. Cold Spring Harbor Laboratory (2021).
B. N. Bell, A. E. Powell, C. Rodriguez, J. R. Cochran, P. S. Kim, Neutralizing antibodies targeting the SARS-CoV-2 receptor binding domain isolated from a naïve human antibody library. Protein Sci. (2021).
J.S. Lee, E.J. Lee, J.H. Lee, S.C. Hong, C.K. Lee, B. Yoo, J.S. Oh, S.H. Lee, T.J. Kim, S.H. Lee, Others, Autoantibodies against Protein Phosphatase Magnesium-Dependent 1A as a Biomarker for Predicting Radiographic Progression in Ankylosing Spondylitis Treated with Anti-Tumor Necrosis Factor Agents. J. Clin. Med. Res. 9, 3968 (2020).
I. Vasquez, T. Cao, A. Hossain, K. Valderrama, H. Gnanagobal, M. Dang, R. H. J. Leeuwis, M. Ness, B. Campbell, R. Gendron, K. Kao, J. Westcott, A. K. Gamperl, J. Santander, Aeromonas salmonicida infection kinetics and protective immune response to vaccination in sablefish (Anoplopoma fimbria). Fish Shellfish Immunol. 104, 557–566 (2020).
J. V. Dzimianski, N. Lorig-Roach, S. M. O’Rourke, D. L. Alexander, J. M. Kimmey, R. M. DuBois, Rapid and sensitive detection of SARS-CoV-2 antibodies by biolayer interferometry. Sci. Rep. 10, 21738 (2020).
S. S. C. Li, S. Esmail, M. Knauer, H. Abdoh, B. Chin-Yee, L. Lowes, C. Voss, B. Hedley, V. Bhayana, I. Chin-Yee, Others, Rapid and accurate point-of-care testing for SARS-CoV2 antibodies. medRxiv (2020)
Z. Montague, H. Lv, J. Otwinowski, W. S. DeWitt, G. Isacchini, G. K. Yip, W. W. Ng, O. T.-Y. Tsang, M. Yuan, H. Liu, I. A. Wilson, M. Peiris, N. C. Wu, A. Nourmohammad, C. K. P. Mok, Dynamics of B-cell repertoires and emergence of cross-reactive responses in COVID-19 patients with different disease severity. medRxiv (2020).
H. Lv, R. T. Y. So, M. Yuan, H. Liu, C.-C. D. Lee, G. K. Yip, W. W. Ng, I. A. Wilson, M. Peiris, N. C. Wu, C. K. P. Mok, Evidence of antigenic imprinting in sequential Sarbecovirus immunization. Cold Spring Harbor Laboratory (2020).
R. A. Perera, C. K. Mok, O. T. Tsang, H. Lv, R. L. Ko, N. C. Wu, M. Yuan, W. S. Leung, J. M. Chan, T. S. Chik, C. Y. Choi, K. Leung, K. H. Chan, K. C. Chan, K.-C. Li, J. T. Wu, I. A. Wilson, A. S. Monto, L. L. Poon, M. Peiris, Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Euro Surveill. 25 (2020).
P. A. Weidenbacher, P. S. Kim, Protect, modify, deprotect (PMD): A strategy for creating vaccines to elicit antibodies targeting a specific epitope. Proc Natl Acad Sci USA. 116(20), 9947–9952 (2019).
M. Ramirez, et al., Characterization of the immune response elicited by the vaccinia virus L3 protein delivered as naked DNA. Vaccine 36(15),2049-2055, (2018).
S. Shikha, X. Zheng, Y. Zhang, Upconversion Nanoparticles-Encoded Hydrogel Microbeads-Based Multiplexed Protein Detection. Nanomicro Lett 10(2),31, (2018).
T. Waritani, J. Chang, B. McKinney, K. Terato, An ELISA protocol to improve the accuracy and reliability of serological antibody assays. Methods X 4, 153-165 (2017).
K. Terato, C. T. Do, H. Shionoya, Slipping through the Cracks: Linking Low Immune Function and Intestinal Bacterial Imbalance to the Etiology of Rheumatoid Arthritis. Autoimmune Dis 2015:636207, (2015).
K.Terato, C. T. Do, D. Cutler, T. Waritani, H. Shionoya, Preventing intense false positive and negative reactions attributed to the principle of ELISA to re-investigate antibody studies in autoimmune diseases. J Immunol Methods 407, 15-25, (2014).
